LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 93 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $239,000 | +78.4% | 32,093 | +66.6% | 0.02% | +27.8% |
| Q4 2016 | $134,000 | -15.7% | 19,262 | 0.0% | 0.02% | -14.3% |
| Q3 2016 | $159,000 | -84.9% | 19,262 | -85.2% | 0.02% | -84.9% |
| Q2 2016 | $1,055,000 | +50.9% | 130,196 | -5.4% | 0.14% | +65.5% |
| Q1 2016 | $699,000 | -1.7% | 137,583 | +49.3% | 0.08% | -5.6% |
| Q4 2015 | $711,000 | +81.4% | 92,131 | +35.2% | 0.09% | +67.9% |
| Q3 2015 | $392,000 | +1.6% | 68,139 | +61.9% | 0.05% | -19.7% |
| Q2 2015 | $386,000 | -19.6% | 42,100 | +6.3% | 0.07% | -48.4% |
| Q1 2015 | $480,000 | – | 39,600 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,232,416 | $26,183,000 | 12.58% |
| Avoro Capital Advisors LLC | 4,338,557 | $35,142,000 | 7.81% |
| FRAZIER MANAGEMENT LLC | 774,720 | $6,275,000 | 5.00% |
| Broadfin Capital, LLC | 3,170,759 | $25,683,000 | 2.50% |
| Perceptive Advisors | 3,611,976 | $29,257,000 | 2.03% |
| Ghost Tree Capital, LLC | 700,000 | $5,670,000 | 1.64% |
| Opaleye Management Inc. | 260,000 | $2,106,000 | 1.41% |
| Rhenman & Partners Asset Management AB | 650,000 | $5,265,000 | 0.94% |
| QVT Financial LP | 1,598,309 | $12,946,000 | 0.89% |
| Cormorant Asset Management, LP | 505,941 | $4,098,000 | 0.58% |